SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CLTR COULTER PHARMACEUTICAL
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
666 17 0 CLTR
Emcee:  HARRY GIBSON Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
291 Thanks for forwarding this and the Prudential comments today. Bexxar approved,Bob L-8/31/1999
290 Kendall, I do not know where the stock will settle in. My guess is low 20s. IVector1-8/31/1999
289 Hey umm I was just thinking that whoever is making that um...whaddayacallit...RBen Wa-8/31/1999
288 Most people forget that once a drug is approved for one indication, the physiciBharat H. Barai-8/31/1999
287 Prudential was quoted all over 'da place - their eehh, technical biotechnicBen Wa-8/31/1999
286 CLTR--From tonight's THESTREET.COM. This article is disappointingly unbalakendall harmon-8/30/1999
285 That quote from the Coulter officer is meaningless. The things he mentioned arsynchro-8/30/1999
284 CLTR--Prudential comments from today, excerpts: <i><b>We would poikendall harmon-8/30/1999
283 Thank you very much for your post. What do you think about the HAMA response iBob L-8/30/1999
282 The data about response rates to Bexaar are simply superb. Even with best chemoBharat H. Barai-8/30/1999
281 Like I said, I know nothing, I'm just confused.Ben Wa-8/30/1999
280 Vector1, you are welcome. I am still sorting through and digesting. I love ovkendall harmon-8/30/1999
279 Kendall, Thanks for the response to HTM. Great day for CLTR shorts. Longs wilVector1-8/30/1999
278 CLTR--more on this one: quote.bloomberg.com <b>''(The FDA) didnkendall harmon-8/30/1999
277 You say their partner had a look at the hot/cold study prior to putting up seriBen Wa-8/30/1999
276 Dennis, I hope so. However the shorts may have a field day with it. V1Vector1-8/30/1999
275 From Reuters story today on FDA request: >>Eric Ende, a pharmaceuticals RCMac-8/30/1999
274 I guess Ralph Cramdon at Prudential never took a biology course. I hope it goeBen Wa-8/30/1999
273 This is now the best buying opportunity I have seen. IMO this will be back to DENNIS TULLY-8/30/1999
272 RC, I saw it when I came in this morning. F-ing FDA. The requested modificatioVector1-8/30/1999
271 FDA requires modifications to CLTR's Bexxar application: Monday August 30,RCMac-8/30/1999
270 Brian, Nice find on the SmartMoney article. Didn't know that Acampora madGordon James-8/30/1999
269 I didn't realize that SKB invested last year & reviewed the "hot/cBen Wa-8/28/1999
268 From a press release last December coulterpharm.comsim1-8/27/1999
267 Roughly when did SKB invest?Ben Wa-8/27/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News